DA Davidson analyst Linda Bolton Weiser raised her price target on Nu Skin to $42, saying that she expects its sales declines in China to begin improving by Q4 of this year. The analyst notes that the company's sales leaders in the market have gradually resumed meetings and also cites her expectation of improved performance from the launch of new ageLoc Galvanic Spa and ageLoc Nutriol hair and scalp systems in Q3. Weiser further cites Nu Skin's new incentives to drive productivity and a new customer referral program but keeps her Neutral rating on the stock, warning that the biggest sales decline in China is still to come with the upcoming Q3 earnings release.